{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:50:13Z","timestamp":1775746213674,"version":"3.50.1"},"reference-count":32,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Korean government, the Ministry of Science, and ICT (MSIP)","award":["NRF- 2020R1A2C1005729"],"award-info":[{"award-number":["NRF- 2020R1A2C1005729"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>A single-center retrospective observational case series was conducted. This case series enrolled patients who showed ophthalmic manifestations within one week after COVID-19 vaccination at Korea University Guro Hospital in Seoul, Korea, from May 2021 to January 2022. The medical records of patients who complained of ocular symptoms and showed ophthalmic adverse events within one week after COVID-19 vaccination were reviewed. Seventeen eyes from 16 patients with a mean age of 63.8 (range 33\u201383) years were included in the case series, and all symptoms developed within 1\u20137 days following inoculation. Retinal vein occlusion in nine eyes (52.9%), retinal artery occlusion in one eye (5.9%), newly developed anterior uveitis in one eye (5.9%), exacerbation of previously diagnosed panuveitis in two eyes (11.8%), and angle-closure attack with high intraocular pressure in four eyes (23.5%) were included. Twelve patients (75%) had been vaccinated with the AstraZeneca (AZD1222) and four (25%) with the Pfizer (BNT162b2) vaccines. Of these, 10 patients (62.5%) experienced ocular disease exacerbation after the first dose, 4 (25%) after the second dose, and 2 (12.5%) after the third dose (booster shot). Eleven patients (64.7%) underwent tests for hematological abnormalities, and three of them tested positive for anti-PF4 antibodies, but no abnormal findings were noted. A causal relationship between vaccination and the ocular manifestations could not be determined, which is a limitation of this study. However, clinicians should consider the effect of COVID-19 vaccination on ophthalmic disease. Further studies are required to elucidate the possible effects of COVID-19 vaccination on the eye.<\/jats:p>","DOI":"10.3390\/jcm11123318","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T02:25:33Z","timestamp":1654827933000},"page":"3318","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Vision-Threatening Ocular Adverse Events after Vaccination against Coronavirus Disease 2019"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2420-0907","authenticated-orcid":false,"given":"Mihyun","family":"Choi","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Korea University Guro Hospital, Korea University Medicine, 148, Gurodong-ro, Guro-gu, Seoul 08308, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Hwan","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Korea University Guro Hospital, Korea University Medicine, 148, Gurodong-ro, Guro-gu, Seoul 08308, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0107-3151","authenticated-orcid":false,"given":"Kwang-Eon","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Korea University Ansan Hospital, Korea University Medicine, 123, Jeokgeum-ro, Danwon-gu, Ansan-si 15355, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukyeon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Korea University Guro Hospital, Korea University Medicine, 148, Gurodong-ro, Guro-gu, Seoul 08308, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyoon","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Korea University Guro Hospital, Korea University Medicine, 148, Gurodong-ro, Guro-gu, Seoul 08308, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheolmin","family":"Yun","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Korea University Ansan Hospital, Korea University Medicine, 123, Jeokgeum-ro, Danwon-gu, Ansan-si 15355, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Woo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Korea University Guro Hospital, Korea University Medicine, 148, Gurodong-ro, Guro-gu, Seoul 08308, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Yeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Korea University Guro Hospital, Korea University Medicine, 148, Gurodong-ro, Guro-gu, Seoul 08308, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"ref_1","unstructured":"The Royal College of Ophthalmologists (2021, May 13). Safety Alert: Retinal Vein Occlusions Post COVID Vaccination. Available online: https:\/\/www.rcophth.ac.uk\/news-views\/safety-alert-retinal-vein-occlusions-post-covid-vaccination\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S0140-6736(21)00872-2","article-title":"Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"397","author":"Bayas","year":"2021","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S0140-6736(21)01238-1","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban","volume":"397","author":"Guetl","year":"2021","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1055\/a-1481-3039","article-title":"Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors","volume":"121","author":"Lorenz","year":"2021","journal-title":"Thromb. Haemost."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Park, H.S., Byun, Y., Byeon, S.H., Kim, S.S., Kim, Y.J., and Lee, C.S. (2021). Retinal Hemorrhage after SARS-CoV-2 Vaccination. J. Clin. Med., 10.","DOI":"10.3390\/jcm10235705"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/jamaophthalmol.2021.3477","article-title":"Association of Ocular Adverse Events with Inactivated COVID-19 Vaccination in Patients in Abu Dhabi","volume":"139","author":"Pichi","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bolletta, E., Iannetta, D., Mastrofilippo, V., de Simone, L., Gozzi, F., Croci, S., Bonacini, M., Belloni, L., Zerbini, A., and Adani, A. (2021). Uveitis and Other Ocular Complications Following COVID-19 Vaccination. J. Clin. Med., 10.","DOI":"10.3390\/jcm10245960"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/09273948.2021.1949478","article-title":"Panuveitis following Vaccination for COVID-19","volume":"29","author":"Mudie","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41433-021-01610-1","article-title":"Acute macular neuroretinopathy following COVID-19 vaccination","volume":"36","author":"Sandvig","year":"2022","journal-title":"Eye"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e212471","DOI":"10.1001\/jamaophthalmol.2021.2471","article-title":"Bilateral Acute Macular Neuroretinopathy After Vaccination Against SARS-CoV-2","volume":"139","author":"Book","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1080\/09273948.2021.1946567","article-title":"Acute Macular Neuroretinopathy following Coronavirus Disease 2019 Vaccination","volume":"29","author":"Mambretti","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Haseeb, A.A., Solyman, O., Abushanab, M.M., Abo Obaia, A.S., and Elhusseiny, A.M. (2022). Ocular Complications Following Vaccination for COVID-19: A One-Year Retrospective. Vaccines, 10.","DOI":"10.3390\/vaccines10020342"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40123-021-00415-5","article-title":"The Eye of the Storm: COVID-19 Vaccination and the Eye","volume":"11","author":"Ng","year":"2022","journal-title":"Ophthalmol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2010.08.047","article-title":"Appropriate use and reporting of uncontrolled case series in the medical literature","volume":"151","author":"Kempen","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3346\/jkms.2013.28.1.136","article-title":"Baseline characteristics and risk factors of retinal vein occlusion: A study by the Korean RVO Study Group","volume":"28","author":"Lee","year":"2013","journal-title":"J. Korean Med. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2021.04.019","article-title":"SARS-CoV-2 vaccines: Lights and shadows","volume":"88","author":"Angeli","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1021\/acscentsci.1c00080","article-title":"Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19\/AZD1222 Vaccine","volume":"7","author":"Watanabe","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"100550","DOI":"10.1016\/j.eclinm.2020.100550","article-title":"Retinal findings in patients with COVID-19: Results from the SERPICO-19 study","volume":"27","author":"Invernizzi","year":"2020","journal-title":"EClinicalMedicine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/s00417-021-05186-0","article-title":"Reduced macular vessel density in COVID-19 patients with and without associated thrombotic events using optical coherence tomography angiography","volume":"259","year":"2021","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.4103\/ijo.IJO_816_20","article-title":"Drug-induced uveitis: A review","volume":"68","author":"Agarwal","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.vaccine.2009.10.115","article-title":"Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies","volume":"28","author":"Klein","year":"2010","journal-title":"Vaccine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/09273948.2019.1626188","article-title":"Vaccine-Associated Uveitis","volume":"27","author":"Cunningham","year":"2019","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3341\/kjo.2020.0033","article-title":"Profiles and Clinical Characteristics of Newly Diagnosed Glaucoma in Urban Korea: A Multicenter Study","volume":"34","author":"Hong","year":"2020","journal-title":"Korean J. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ha, J.Y., Sung, M.S., Heo, H., and Park, S.W. (2019). Trends in the characteristics of acute primary angle closure in Korea over the past 10-years. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0223527"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/bjo.86.6.676","article-title":"Renin-angiotensin system expression and secretory function in cultured human ciliary body non-pigmented epithelium","volume":"86","author":"Cullinane","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/bjophthalmol-2020-316075","article-title":"Iris and its relevance to angle closure disease: A review","volume":"105","author":"Soh","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e951","DOI":"10.1111\/aos.14472","article-title":"Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: A cross-sectional study","volume":"98","author":"Chen","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/ICU.0000000000000801","article-title":"Retinal and choroidal manifestations of COVID-19","volume":"32","author":"Zhang","year":"2021","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/09273948.2020.1770301","article-title":"Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients","volume":"28","author":"Casagrande","year":"2020","journal-title":"Ocul. Immunol. Inflamm."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/12\/3318\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:27:09Z","timestamp":1760138829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/12\/3318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["jcm11123318"],"URL":"https:\/\/doi.org\/10.3390\/jcm11123318","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]}}}